Reconstitution of the peripheral B lymphocyte compartment in patients with ANCA-associated vasculitides treated with rituximab for relapsing or refractory disease

B cell homeostasis is disturbed by immunosuppressive therapies in patients with ANCA-associated vasculitides

(2013) Jens Thiel et al.   AUTOIMMUNITY

B cells participate in tolerance and autoimmunity through cytokine production

(2013) Van Phi Luu et al.   AUTOIMMUNITY

Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis

(2013) Ulrich Specks et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): Ten-year experience at a single center

(2012) Rodrigo Cartin-Ceba et al.   ARTHRITIS AND RHEUMATISM

Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis

(2012) Rona M. Smith et al.   ARTHRITIS AND RHEUMATISM

Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides

(2012) Nils Venhoff et al.   PLoS One

Off-Trial Evaluation of the B cell-Targeting Treatment in the Refractory Cases of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis: Long-Term Follow-Up from a Single Centre

(2012) R. Pullerits et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Progress in treatment of ANCA-associated vasculitis

(2012) Rona M Smith et al.   ARTHRITIS RESEARCH & THERAPY

ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process

(2011) N. J. Holden et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab

(2011) Rodrigo Cartin-Ceba et al.   CURRENT OPINION IN RHEUMATOLOGY

Soluble BAFF Levels Inversely Correlate with Peripheral B Cell Numbers and the Expression of BAFF Receptors

(2011) M. Kreuzaler et al.   JOURNAL OF IMMUNOLOGY

Rituximab Maintenance Therapy for Granulomatosis with Polyangiitis and Microscopic Polyangiitis

(2011) C. ROUBAUD-BAUDRON et al.   JOURNAL OF RHEUMATOLOGY

Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients

(2011) M Wendt et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosis

(2010) Randi Y. Leavitt et al.   ARTHRITIS AND RHEUMATISM

Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

(2010) E. P. Rhee et al.   Clinical Journal of the American Society of Nephrology

Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

(2010) Thomas F. Hiemstra et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis

(2009) Rachel B. Jones et al.   ARTHRITIS AND RHEUMATISM

EULAR recommendations for the management of primary small and medium vessel vasculitis

(2008) C Mukhtyar et al.   ANNALS OF THE RHEUMATIC DISEASES

Modulation of molecular imprints in the antigen-experienced B cell repertoire by rituximab

(2008) Arumugam Palanichamy et al.   ARTHRITIS AND RHEUMATISM

Anti-CD20 therapy in patients with rheumatoid arthritis: Predictors of response and B cell subset regeneration after repeated treatment

(2008) Petra Roll et al.   ARTHRITIS AND RHEUMATISM

Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis

(2008) Christian Pagnoux et al.   NEW ENGLAND JOURNAL OF MEDICINE